Novel framework for determining TPS-calculated doses corresponding to detector locations using 3D camera in in vivo surface dosimetry. (23rd February 2023)

• Record Type: Journal Article
• Authors: Sheen, Heesoon; Park, Ye-in; Cho, Min-Seok; Son, Junyoung; Shin, Han-Back; Han, Min Cheol; Kim, Hojin; Lee, Ho; Kim, Dong Wook; Kim, Jin Sung; Hong, Chae-Seon
• Is Part Of: Physics in medicine & biology. Volume 68:Number 5(2023)
• Publication Date: 2023-02-23
• Subjects: In vivo dosimetry -- surface dose -- planned dose -- detector -- optically stimulated luminescent dosimeter -- radiation therapy; Biophysics -- Periodicals; Medical physics -- Periodicals; 610.153
• DOI: 10.1088/1361-6560/acba78
• Languages: English
• ISSNs: 0031-9155

Abstract

Abstract: Purpose . To address the shortcomings of current procedures for evaluating the measured-to-planned dose agreement in in vivo dosimetry (IVD), this study aimed to develop an accurate and efficient novel framework to identify the detector location placed on a patient's skin surface using a 3D camera and determine the planned dose at the same anatomical position corresponding to the detector location. Methods . Breast cancer treatment was simulated using an anthropomorphic adult female phantom (ATOM 702D; CIRS, Norfolk, VA, USA). An optically stimulated luminescent dosimeter was used for surface dose measurements (MyOSLchip, RadPro International GmbH, Germany) at six IVD points. Three-dimensional surface imaging (3DSI) of the phantom with the detector was performed in the treatment position using a 3D camera. The developed framework, iSMART, was designed to import 3DSI and treatment planning data for determining the position of the IVD detectors in the 3D treatment planning DICOM image. The clinical usefulness of iSMART was evaluated in terms of accuracy and efficiency, for comparison with the results obtained using cone-beam computed tomography (CBCT) image guidance. Results . The relative dose difference between the planned doses determined using iSMART and CBCT images displayed similar accuracies (within approximately ±2.0%) at all detector locations. The relative dose differences between the planned and measured doses at the six detector locations ranged from –4.8% to 3.1% for the CBCT images and –3.5% to 2.1% for iSMART. The total time required to read the planned doses at six detector locations averaged at 8.1 and 0.8 min for the CBCT images and iSMART, respectively. Conclusions . The proposed framework can improve the robustness of IVD analyses and aid in accurate and efficient evaluations of the measured-to-planned dose agreement.